What's new? Log in Free sign up

Lucira Health (LHDX) News and press releases

Company Profile

News

From Benzinga Pro

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Short Sellers, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences.

12 Health Care Stocks Moving In Thursday's Intraday Session

Sesame Partners With Lucira Health As Official Telehealth Provider Of Lab-Quality Test-To-Treat Program

New partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the comfort of home, within two hours NEW

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.

Lucira Health Launched Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada

News, Penny Stocks

Lucira Health, Inc.

12 Health Care Stocks Moving In Tuesday's After-Market Session

Nasdaq Down 1%; Crude Oil Falls Sharply

News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Tuesday.

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.

Why Lucira Health Shares Are Trading Higher Today

News, Penny Stocks, FDA, Movers, Trading Ideas

Lucira Health, Inc. (NASDAQ: LHDX) shares are surging higher on Tuesday after the company announced it submitted an Emergency Use Authorization application to the FDA for over-the-counter use of its COVID-19 & Flu test.

Press releases

From Benzinga Pro

Thinking about buying stock in WiSA Technologies, Arrival, Marathon Digital, Lucira Health, or Hut 8 Mining?

Opinion, Press Releases

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WISA, ARVL, MARA, LHDX, and HUT.

Thinking about buying stock in Mullen Automotive, Humanigen, Vyant Bio, IQIYI, or Lucira Health?

Small Cap, Opinion, Press Releases

NEW YORK, Jan. 5, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, HGEN, VYNT, IQ, and LHDX.

SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM

New partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the comfort of home, within two hours NEW YORK , Jan. 5, 2023

Thinking about buying stock in Crown Electrokinetics, Lucira Health, Enovix, Shift Technologies, or IQIYI?

Opinion, Press Releases

NEW YORK, Jan. 4, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRKN, LHDX, ENVX, SFT, and IQ.

Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada

Press Releases, General

For $98 CAD Canadians will receive a free telehealth appointment included with purchase of a testLucira Connect provides lab-quality at-home test-users a telehealth visit at no additional cost, enabling Test-to-Treatment

Thinking about buying stock in Lucira Health, RedHill Biopharma, Plug Power, IQIYI, or Bilibili?

Opinion, Press Releases

NEW YORK, Jan. 3, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LHDX, RDHL, PLUG, IQ, and BILI.

Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test

Health Care, Press Releases

EMERYVILLE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced that it submitted an Emergency Use

Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test

Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and visitors amid the

Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care

Health Care, Press Releases, General

PCR Lab-quality NAAT/molecular test for both COVID-19 and flu from 1 shallow nasal swabPositive result as quickly as 11 minutes, negative result in 30 minutes, allowing diagnosis during patient visitEquipment-free Lucira

Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service

Health Care, Press Releases

Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira partners with Pfizer

Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates

Earnings, Press Releases

EMERYVILLE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and